[ad_1] SUZHOU, China and ROCKVILLE, Md. , Aug. 21, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and…